EUVIMEDEUVIMED entdecken
Crossref

Endothelial KLK8 Promotes Diabetic Nephropathy via a LIFR Dependent Mechanism

Jiankui Du, Mingyang Li, Ying Jiang, Zhengshan Tang, Danhong Xu, Hongling Yin, Jihong Yuan, Xiaoyan Zhu iD, Xin Ni iD

Circulation Research · 09.11.2026

DOI: 10.1161/circresaha.125.327042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, online erschienen am 09.11.2026. Verfasst von Jiankui Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Geriatric Diseases (J.D., M.L., Y.J., X.N.), Xiangya Hospital, Central South University, Changsha, Hunan, China. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The molecular pathways in endothelial cells (ECs) in diabetic nephropathy (DN), a primary microvascular complication of diabetes, remain unclear. Tissue KLKs (kallikrein-related peptidases) participate in pathophysiological processes in ECs. We aimed to explore the roles of endothelial KLKs in DN and define the underlying mechanisms. METHODS AND RESULTS: Renal KLK8 was the most highly upregulated KLK in streptozotocin-induced diabetic mice and cultured glomerular ECs (GECs) upon high glucose treatment. C57/BL6 background global ( Klk8 −/− ) and endothelial Klk8 knockout ( Klk8 ΔEC ) mice, as well as DBA/2J mice with endothelial Klk8 knockdown, displayed improved albuminuria, mesangial matrix expansion, and glomerulosclerosis caused by streptozotocin compared with the corresponding wild-type mice. Single-cell RNA sequencing showed that many pathways linked to DN in ECs, mesangial cells, and tubule cells were reversed in Klk8 ΔEC mice. Endothelial-to-mesenchymal transition caused by streptozotocin was extensively improved in Klk8 ΔEC mice, which was confirmed in Cdh5CreERT2 +/− -mT/mG +/− mice with endothelial Klk8 knockdown. Proteome coupled with other approaches revealed that KLK8 cleaved SDC4 (syndecan-4), which contributed to the loss of glycocalyx integrity in GECs during DN progress. Lifr was one of the key genes in ECs and mesangial cells regulated by endothelial Klk8 during DN progress. Endothelial KLK8 upregulated LIFR (leukemia inhibitory factor receptor) expression through PLC (phospholipase C)/ERK (extracellular signal-regulated kinase)/RUNX1 (runt-related transcription factor)1 pathways, and upregulated LIFR contributed to high glucose–induced GEC dysfunction and MC activation. Knockdown of Lifr ameliorated hallmark features of DN and improved endothelial-to-mesenchymal transition and SDC4 expression in the glomeruli of diabetic mice. LIFR was upregulated in GECs and mesangial cells in patients with DN. Circulatory LIF (leukemia inhibitory factor), KLK8 and soluble SDC4 levels were increased in patients with DN, and KLK8 level was positively correlated with LIF, soluble SDC4 and creatinine levels. CONCLUSIONS: Endothelial KLK8 promotes GEC dysfunction and abnormal crosstalk with mesangial cells through a LIFR-dependent signaling in DN, which immediately highlights therapeutic targets for DN.

Schlagwörter

Stichwörter der Autor:innen

angiopoietinendothelial cellmesangial cellsstreptozotocintherapeutics

Autor:innen und Institutionen

  • National Clinical Research Center for Geriatric Diseases (J.D., M.L., Y.J., X.N.), Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National International Joint Research Center for Medical Metabolomics (J.D., M.L., Z.T., X.N.), Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Physiology, Navy Medical University, Shanghai, China (J.D., X.Z.).
  • Department of Infectious Disease (Y.J.), Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of General Medicine (D.X.), Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • School of Kinesiology, Shanghai University of Sport, China (D.X.).

ORCID-Profile: Xiaoyan Zhu, Xin Ni

Zitieren

APA

Du, J., Li, M., Jiang, Y., Tang, Z., Xu, D., Yin, H., Yuan, J., Zhu, X., & Ni, X. (2026). Endothelial KLK8 Promotes Diabetic Nephropathy via a LIFR Dependent Mechanism. Circulation Research. https://doi.org/10.1161/circresaha.125.327042

Vancouver

Du J, Li M, Jiang Y, Tang Z, Xu D, Yin H, et al. Endothelial KLK8 Promotes Diabetic Nephropathy via a LIFR Dependent Mechanism. Circulation Research. 2026. doi:10.1161/circresaha.125.327042

BibTeX
@article{Du2026,
  author = {Du, Jiankui and Li, Mingyang and Jiang, Ying and Tang, Zhengshan and Xu, Danhong and Yin, Hongling and Yuan, Jihong and Zhu, Xiaoyan and Ni, Xin},
  title = {Endothelial KLK8 Promotes Diabetic Nephropathy via a LIFR Dependent Mechanism},
  journal = {Circulation Research},
  year = {2026},
  doi = {10.1161/circresaha.125.327042}
}
Kostenlos starten →